The Cochrane Collaboration's tool for assessing risk of bias in randomised trials - sprookjes - yvandenbroek - TriplyDB

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

http://www.wikidata.org/entity/Q27860509

about

Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials Long-term effects of low-fat diets either low or high in protein on cardiovascular and metabolic risk factors: a systematic review and meta-analysis Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups Reappraisal of thienopyridine pretreatment in patients with non-ST elevation acute coronary syndrome: a systematic review and meta-analysis Early interventions to prevent psychosis: systematic review and meta-analysis Cognitive behavioural therapy for psychosis prevention: a systematic review and meta-analysis Dipeptidyl-peptidase (DPP)-4 inhibitors or glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus Interventions for the prevention of type 2 diabetes mellitus in women with previous gestational diabetes Fructose substitution of glucose or sucrose in food for normoglycaemic persons or people with or at risk of diabetes Probiotic fermented milk or isolated probiotic bacteria for primary prevention of cardiovascular disease in adults Self management interventions for type 2 diabetes in adult people with severe mental illness Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus PI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancer Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus Perioperative fluid volume optimization following proximal femoral fracture Therapist-supported Internet cognitive behavioural therapy for anxiety disorders in adults Diet, physical activity, and behavioural interventions for the treatment of overweight or obesity in preschool children up to the age of 6 years Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates Psychological interventions for adults who are overweight or obese Sodium-glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for development of type 2 diabetes mellitus Lorcaserin for overweight or obese adults Radioiodine therapy versus antithyroid medications for Graves' disease Pylorus-preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression-free survival in patients with advanced and/or metastatic colorectal cancer Ayurvedic herbal preparations for hypercholesterolaemia Acupuncture for adults with type 2 diabetes mellitus Psychosocial interventions for the maintenance of weight loss in obese adults Structured telephone support or non-invasive telemonitoring for patients with heart failure Deworming drugs for soil-transmitted intestinal worms in children: effects on nutritional indicators, haemoglobin, and school performance Subcutaneous rapid-acting insulin analogues for diabetic ketoacidosis Intra-articular corticosteroid for knee osteoarthritis Balneotherapy (or spa therapy) for rheumatoid arthritis Aromatase inhibitors for short stature in male children and adolescents Yoga for adults with type 2 diabetes mellitus Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for adrenal tumours in adults Vitamin D supplementation for obese adults undergoing bariatric surgery Pharmacological and psychosocial interventions for night eating syndrome in adults Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP)Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates Carbohydrate or fat-restricted diets for obesity

P2860

Q21089763-FE899C01-4ECB-4D87-B1D3-C9E1A994D482 Q21245914-CE2D5BF3-544B-4B88-AA88-1D05420302F0 Q21284803-BF2671A3-9717-43F6-A4D2-F48562117CB8 Q22242057-D76A015A-905E-47EB-BB9F-674F28AB4D57 Q22242061-1DE848BC-AED2-48E2-BE55-60D90A3AA1CC Q22251382-EC424D96-A63D-490F-B22F-8C6DD8286D33 Q24185805-81A5E2A1-7909-4A68-AFE9-2A4869E24AA7 Q24185836-4ABBCF42-8460-4255-9E5B-C9F01B3C5623 Q24185843-707A9A3A-8560-4A78-87D6-B8138ED9BC5D Q24185844-72181DEB-70F3-457F-B698-FFB768BA280A Q24185857-91173FE1-DD6C-42B6-814B-543AE2ED3BF4 Q24185874-4B599A7B-C444-4555-8DE9-A4F267EE7570 Q24185960-DDED25B7-2895-47F0-8DE3-4B075B90AAB1 Q24185970-02A65EE1-2C50-4554-9487-D93DCD885A73 Q24186030-92B463EF-041E-47C5-8B41-D6E421082E04 Q24186033-59607326-2A12-42B6-B676-3CED4F1E3C2C Q24186038-AF747B25-9139-4493-AC33-129A2C4740CD Q24186056-737B09EA-79D8-4A89-8ECC-45154B71E617 Q24186064-76078445-326C-4525-B70F-0FAA0F4DF338 Q24186087-E0689C48-FC01-4AEF-9520-A78D80E4213F Q24186092-24D30D35-E6B7-417B-B89C-C4540E1D3848 Q24186122-4E747B64-0A72-467E-9415-D7D1689CA4D1 Q24186132-0D573F69-573B-41D4-875E-8950658AF994 Q24186145-C96C9BB5-8A73-4348-B608-BE4D010C7BB0 Q24186216-3F078889-1AE1-47B6-8EB5-4AA88990DF84 Q24186271-A32E8149-6E27-4A7C-BEE2-A4863EB83847 Q24186273-4D560E6B-1BAA-419E-8126-86E2775C0BE1 Q24186286-2882654F-4661-42B6-8C12-861127F35431 Q24186330-2F755482-CDA1-4888-ABE7-100A9ACED98C Q24186409-FE35C54A-6DD3-479D-ACD6-F7A08892462C Q24186414-5A2AD842-C37D-4CAF-A42F-7CEA5F57BD92 Q24186540-C5768491-A881-4080-A986-2F8ACB1F7646 Q24186574-9D05831B-9BCC-4B3E-9A91-D03BC896C2C5 Q24186693-9B1A4AAB-1C7B-4502-B735-3CE7A245A777 Q24186722-21B35A19-90BC-41BD-8827-65D04CCA3C06 Q24186730-8DAB73B1-2496-4404-98F7-497FB3ECC906 Q24186735-05426F98-CAF7-4F36-AD65-A5684A22BE8D Q24186769-6860422C-A0BB-4FB4-9B1F-986E121DAF77 Q24186824-E9227AC0-3633-42E0-B5D2-23CACDDCCFE2 Q24186847-7074B23D-7082-4EB9-8987-821803E1CE14

P2860

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

http://www.wikidata.org/entity/Q27860509

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@ast

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@da

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@de

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@en

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@fo

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@fr

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@is

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@kl

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@nb

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@nl

type

label

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@ast

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@da

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@de

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@en

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@fo

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@fr

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@is

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@kl

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@nb

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@nl

prefLabel

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@ast

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@da

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@de

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@en

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@fo

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@fr

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@is

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@kl

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@nb

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@nl

P1433

Q27860509-46949FB2-4532-4075-B25D-8AC7DB4CE33A

P1476

Q27860509-EF8B07A3-4C3C-40DB-8745-7E7507EDB3C7

P2093

Q27860509-39043416-4D65-41F6-939B-3673A28BB405

Q27860509-8F635832-C4E9-4AA8-B435-8408557B9ED8

Q27860509-B024E15E-0AF5-4B53-8C03-5E0A807F8701

P2860

Q27860509-00AC1B74-FC33-46C1-9A7A-F740F3B925D2

Q27860509-0214512E-3B40-4434-8D57-CA79CD495CEE

Q27860509-194C864F-9332-411A-B30D-18C8ECFFE429

Q27860509-3C8FD1BF-17D4-44FB-84C8-030EB5950E89

Q27860509-5650EFEA-A5D3-4BE1-9695-32343CAF2760

Q27860509-83AE0546-E9E7-4AAE-A15F-89467C5E7BC9

Q27860509-8549AF23-5886-4A3C-832E-D843945669AE

Q27860509-8A36EDF2-1ED0-405D-958E-86B757920136

Q27860509-93223379-0310-4987-9C38-F22CBBBE1360

Q27860509-97092878-D108-4AB5-893C-9D589CD543BC

P304

Q27860509-597A61FE-6A43-4FB0-B69C-B857109E4F6A

P31

Q27860509-70833A54-1673-4C21-BF64-3BF13FCA319A

P3181

Q27860509-44B21B50-5727-4529-B117-B82B0345555D

P356

Q27860509-A4768483-4BD2-4D77-A2A7-FC83C3C48AE9

P407

Q27860509-2B0EBAE5-D9B8-4210-A152-FFDE809976FA

P433

Q27860509-AC1D9E20-9FCE-40EB-8E21-D8419F5D46D1

P478

Q27860509-1F8A14A2-3506-46C4-B29A-6C2FA3A6806C

P50

Q27860509-2A59CCE6-B939-4142-B645-0EA640DA2952

Q27860509-757F21D9-4A57-4A5C-AC61-3D00F2D3E450

Q27860509-7D1D6740-35B9-4604-A12A-15A17A9D3487

Q27860509-7E659C92-1E83-4024-A545-1960DDFD37D0

Q27860509-803668A5-9424-4741-AF57-3D1C3C7F11A8

Q27860509-8CD76F36-BAB9-4386-8A0C-F3D30E83BA4B

Q27860509-ea8318ed-48b2-9259-4ce7-94c387a372b5

P577

Q27860509-5A28C834-88D2-4B12-9371-F982F7ADEB44

P5875

Q27860509-DF323448-5122-4458-8925-1EACD7197206

P698

Q27860509-3CC99ECB-3FEC-4CC9-A0A9-03C252CD1A9B

P921

Q27860509-B110E28F-F541-4F23-B016-729EC789F169

Q27860509-EA460B47-2FAB-430D-B722-5D39B4A12BE0

P932

Q27860509-E771A931-07E1-4948-BB65-571D78CB8691

P3181

P356

P1433

P1476

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

@en

P2093

Jonathan A C Sterne

http://www.w3.org/2001/XMLSchema#string

Kenneth F Schulz

http://www.w3.org/2001/XMLSchema#string

Laura Weeks

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic drug monitoring of antiretrovirals for people with HIV

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations

Systematic reviews in health care: Assessing the quality of controlled clinical trials

The hazards of scoring the quality of clinical trials for meta-analysis

Recommendations by Cochrane Review Groups for assessment of the risk of bias in studies.

Discrepancies between meta-analyses and subsequent large randomized, controlled trials.

Low molecular weight heparin in prevention of perioperative thrombosis.

Controlling the risk of spurious findings from meta-regression.

Bias in clinical intervention research.

P304

d5928

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

47629

http://www.w3.org/2001/XMLSchema#string

P356

10.1136/BMJ.D5928

http://www.w3.org/2001/XMLSchema#string

P407

P433

oct18 2

http://www.w3.org/2001/XMLSchema#string

P478

343

http://www.w3.org/2001/XMLSchema#string

P50

Douglas G. Altman

Jelena Savović

Andrew D. Oxman

Peter C. Gøtzsche

P577

2011-10-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51728810

http://www.w3.org/2001/XMLSchema#string

P698

22008217

http://www.w3.org/2001/XMLSchema#string

P921

P932

3196245

http://www.w3.org/2001/XMLSchema#string